EDIT Company Profile Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range. Stock analysis for Editas Medicine Inc (EDIT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. EDIT Stock Overview. A clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. View today's Editas Medicine Inc stock price and latest EDIT news and analysis. Create real-time notifications to follow any changes in the live stock. Latest EDIT news ; am ET Editas Medicine Hold Rating with Revised Price Target Amidst Mixed Financial Signals ; am ET Buy Rating for Editas Medicine.
EDIT — Editas Medicine Share Price · Zoom · 1m · 3m · 6m · YTD · 1y ▾ · 2y · 3y. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. EDIT will report Stock Quote & Chart ; Today's High; $ ; Today's Low; $ ; 52 Week High; $ ; 52 Week Low; $ What is Editas Medicine Inc(EDIT)'s stock price today? The current price of EDIT is $ The 52 week high of EDIT is $ and 52 week low is $ When is. Historical daily share price chart and data for Editas Medicine since adjusted for splits and dividends. The latest closing stock price for Editas. On Thursday 08/22/ the closing price of the Editas Medicine Inc share was $ on BTT. Compared to the opening price on Thursday 08/22/ on BTT of. Editas Medicine Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Editas Medicine Inc ; Previous Close: ; Open: ; Volume: , ; 3 Month Average Trading Volume: ; Shares Out (Mil): Looking to buy Editas Medicine Stock? View today's EDIT stock price, trade commission-free, and discuss EDIT stock updates with the investor community. Discover historical prices for EDIT stock on Yahoo Finance. View daily, weekly or monthly format back to when Editas Medicine, Inc. stock was issued. Based on short-term price targets offered by 13 analysts, the average price target for Editas Medicine comes to $ The forecasts range from a low of $
Quote Overview ; 52 Wk Low: ; 52 Wk High: ; 20 Day Avg Vol: 1,, ; Market Cap: M ; Dividend: (%). Editas Medicine Inc. · · Partner Center · Your Watchlists · Recently Viewed Tickers · EDIT Overview · Key Data · Performance · Analyst Ratings. Sell. Discover real-time Editas Medicine, Inc. Common Stock (EDIT) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Stock Price Forecast. The 10 analysts with month price forecasts for Editas Medicine stock have an average target of , with a low estimate of and a. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. (NASDAQ: EDIT) Editas Medicine stock price per share is $ today (as of Aug 23, ). What is Editas Medicine's Market Cap. 1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $ Is It a Buy Around $5? The company has great potential if and when it enters the commercial. The current price of EDIT is USD — it has increased by % in the past 24 hours. Watch Editas Medicine, Inc. stock price performance more closely on the. Key Turning Points ; 2nd Resistance Point, ; 1st Resistance Point, ; Last Price, ; 1st Support Level, ; 2nd Support Level,
Track Editas Medicine Inc (EDIT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Editas Medicine Inc EDIT:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date12/06/23 · 52 Week Low · EDIT - Editas Medicine, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS). EDIT Stock Performance ; Previous close, 4 ; Day range, - ; Year range, 3 - 11 ; Market cap, ,, ; Primary exchange, NASDAQ. Stock prices are delayed, the delay can range from a few minutes to several hours. Company logos are from the p-x.site logo database and belong to.
Editas Medicine, Inc. (p-x.site): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Editas Medicine, Inc. | Nasdaq: EDIT. Volume, 2M. Market Value, $M. Shares Outstanding, M. EPS (TTM), -$ P/E Ratio (TTM), N/A. Dividend Yield, N/A. Latest Dividend, N/A. Get the latest Editas Medicine Inc. (EDIT) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
Money Orders Online Credit Card | Product Brand Awareness